Medindia
Medindia LOGIN REGISTER
Advertisement

EmSense Announces Release of Revolutionary EmBand 24(TM)

Monday, March 22, 2010 General News
Advertisement


SAN FRANCISCO, March 22 EmSense Corporation, the company that created the first scalable electroencephalography (EEG) brainwave measurement technology, today announced the addition of the EmBand 24(TM) to the EmBand(TM) family of neuromarketing measurement devices.
Advertisement

(Photo: http://www.newscom.com/cgi-bin/prnh/20100322/AQ74210)

Using its Made for Purpose(TM) design, EmSense has employed several new proprietary technologies in the release of the new EmBand 24, including Sensor Fusion Processors(TM), Contact Clusters(TM) and Through the Hair EEG(TM). The headset is designed specifically for market research and overcomes many limitations of using medical EEG for market research.
Advertisement

"Now marketers can have more extensive, robust measurements without trading off consumer comfort, quantitative samples or ease of use," says Keith Winter, EmSense CEO.

EmSense proprietary sensors provide more targeted measurement with greater precision than medical sensors. The Contact Cluster technology enables the ability to take individual anatomical differences into account and give maximum spatial resolution in targeted regions. New Through the Hair EEG sensors allow non-obtrusive measurement without the need for unpleasant, messy gels that require respondent clean-up.

Using 24 EEG sensors, each measuring at 20,000 times per second, the headset collects 480,000 measurements per second. In addition, the EmBand 24 provides an unparalleled signal-to-noise ratio in real-world, in-context conditions. In keeping with the company's non-invasive design philosophy, the EmBand 24 headset does not require caps, gels or wires and calibrates in only one minute.

"With the global availability of the EmBand 24," according to Chief Analytics Officer Elissa Moses, "the ability to objectively understand consumer engagement and emotional response will ultimately accelerate the success rate for ad campaigns, package restages and new product introductions."

The EmBand 24 affords clients increased measurement in the key decision center area of the frontal lobes, as well as added measurements such as visual attention from sensing additional areas of the brain. The new EmBand 24 will primarily be utilized for in-context studies such as in-store shopper research and product innovation, while the current EmBand will continue to be used for advertising, concepts, media content, package testing, online marketing and web-site usability.

About EmSense

EmSense is a leading-edge neuroscience company that applies advances in EEG and other neurometrics to provide clients with deep and reliable understanding of consumers' emotional and cognitive engagement with marketing stimuli. The company's quantitative metrics deliver breakthrough insights that facilitate the creation and optimization of advertising, concepts, packaging, media content, online marketing, web-site usability and both the live in-store and virtual store shopping experiences. EmSense works directly with marketers and also partners with a variety of leading established market research firms including Dynamic Logic, Fifth Dimension, GfK North America, IRI, Millward Brown, Perception Research Services, Red Dot Square and TNS. EmSense provides expertise and advancements in emotion tracking, cognitive neuroscience, analytics, and market research through their proprietary EmBand and now EmBand 24, the first ever wireless, scalable, non-gel, non-invasive EEG neuroscience technology. The company is also the global leader in combining neurometrics with stationary and mobile eye tracking. EmSense Corporation is headquartered in San Francisco. To learn more about EmSense technology applications and neuroscience market research solutions, visit www.emsense.com.

SOURCE EmSense
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close